Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glial Tumor of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT04081701
What this trial is testing

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

Who this might be right for
CNS TumorsMeningiomaEsthesioneuroblastoma+4 more
Weill Medical College of Cornell University 200
Post-approval studies (Phase 4)Study completedNCT02193568
What this trial is testing

Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy

Who this might be right for
Adult Brain Tumor
Ohio State University Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT00020150
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06776250
What this trial is testing

Study of How Safe and Effective Tarlatamab is in Brain Cancers

Who this might be right for
Astrocytic TumorOligodendroglial Tumor
University Health Network, Toronto 44
Testing effectiveness (Phase 2)Ended earlyNCT01868906
What this trial is testing

FMISO-PET in Brain Tumors and SCS Effect

Who this might be right for
Malignant Glioma
Bernardino Clavo, MD, PhD 6
Not applicableNot Yet RecruitingNCT07029100
What this trial is testing

Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.

Who this might be right for
Glioblastoma
Centre Henri Becquerel 30
Not applicableStudy completedNCT07238322
What this trial is testing

[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

Who this might be right for
Retrospective StudyGliomaBrain Neoplasms
Telix Pharmaceuticals (Innovations) Pty Limited 253
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Study completedNCT01213407
What this trial is testing

Dendritic Cell Cancer Vaccine for High-grade Glioma

Who this might be right for
Glioblastoma Multiforme
Activartis Biotech 87
Testing effectiveness (Phase 2)Ended earlyNCT02684071
What this trial is testing

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent Childhood EpendymomaChildhood Atypical Teratoid/Rhabdoid Tumor+2 more
Nicklaus Children's Hospital f/k/a Miami Children's Hospital 3
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Early research (Phase 1)Study completedNCT02105233
What this trial is testing

Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid

Who this might be right for
Brain NeoplasmsGlioma
St. Olavs Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02052648
What this trial is testing

Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors

Who this might be right for
Glioblastoma MultiformeGliomaGliosarcoma+1 more
NewLink Genetics Corporation 160
Testing effectiveness (Phase 2)Study completedNCT00823459
What this trial is testing

Everolimus in Treating Patients With Recurrent Low-Grade Glioma

Who this might be right for
Adult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+2 more
Susan Chang 58
Testing effectiveness (Phase 2)Study completedNCT03475186
What this trial is testing

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Who this might be right for
GlioblastomaRadiotherapy; ComplicationsCognitive Decline+1 more
Wake Forest University Health Sciences 75
Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Early research (Phase 1)Ended earlyNCT03250299
What this trial is testing

Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaMGMT-Unmethylated Glioblastoma
Basilea Pharmaceutica 26
Testing effectiveness (Phase 2)Study completedNCT01931098
What this trial is testing

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma+2 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00314808
What this trial is testing

A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas

Who this might be right for
Brain NeoplasmsNauseaVomiting
Duke University 33
Testing effectiveness (Phase 2)Study completedNCT00006358
What this trial is testing

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Next Page